| Enhanced external counterpulsation is an effective treatment for Syndrome X. | |
| | |
MedLine Citation:
|
PMID: 18590931 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Enhanced external counterpulsation (EECP) was used to treat 30 patients with refractory angina due to cardiac Syndrome X, with an initial improvement in CCS angina class (3.57 to 1.43; p<0.001) and regional ischemia in all treated patients. At a mean of 11.9 months follow-up, 87% of patients had sustained improvement in angina and were without MACE. EECP, by improving endothelial function, may be an effective and durable treatment for this often difficult to treat problem. |
| | |
Authors:
|
Kenneth D Kronhaus; William E Lawson |
Publication Detail:
|
Type: Clinical Trial; Letter Date: 2008-06-30 |
Journal Detail:
|
Title: International journal of cardiology Volume: 135 ISSN: 1874-1754 ISO Abbreviation: Int. J. Cardiol. Publication Date: 2009 Jun |
Date Detail:
|
Created Date: 2009-06-15 Completed Date: 2009-09-01 Revised Date: 2011-03-28 |
Medline Journal Info:
|
Nlm Unique ID: 8200291 Medline TA: Int J Cardiol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 256-7 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Counterpulsation* Female Humans Male Microvascular Angina / surgery* Middle Aged Treatment Outcome |
| Comments/Corrections | |
Comment In:
|
Int J Cardiol. 2010 Aug 6;143(1):94-5
[PMID:
19117626
]
Int J Cardiol. 2011 Mar 3;147(2):283 [PMID: 19732974 ] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The effect of surface demineralization of cortical bone allograft on the properties of recombinant a...
Next Document: Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease.